Beijing Friendship Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1952-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- https://www.bfh.com.cn
Relationship Between Level of GPCR Autoantibodies and Cardiac Structure & Funtions Based on UCG and CMR
- Conditions
- STEMI
- First Posted Date
- 2022-05-10
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 1
- Registration Number
- NCT05368584
- Locations
- 🇨🇳
Beijing Friendship Hospital, Beijing, China
Selinexol Combined With Dexamethasone in the Treatment of CAEBV
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2022-04-26
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT05347381
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
Relationship Between Perioperative Related Factors and Inflammatory Markers and Postoperative Delirium in Elderly Patients With Non-cardiac Major Surgery
Not yet recruiting
- Conditions
- Preoperative Sleep DisorderInflammatory ReactionPreoperative AnxietyPostoperative Delirium
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT05341531
Analysis of Influencing Factors of Hypotension in Diabetic Patients Undergoing Dialysis
- Conditions
- HemodialysisDiabetes
- Interventions
- Combination Product: This is an observational study
- First Posted Date
- 2022-04-13
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT05325892
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Zanubrutinib for HLH
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT05320575
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
Subcutaneous Closed-Suction Drainage Affects Surgical Wounds Healing in Lower Gastrointestinal Open Surgery: a Randomized Controlled Study
Phase 2
- Conditions
- All Diseases That Require Gastrointestinal Open Surgery
- Interventions
- Device: Subcutaneous closed-suction drainage device
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 228
- Registration Number
- NCT05318430
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH
Phase 3
Not yet recruiting
- Conditions
- Hemophagocytic Lymphohistiocytosis
- Interventions
- Drug: L-DEP and PD-1 antibody
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2022-04-26
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05315336
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
Clinical Analysis of a Risk-graded and Comprehensive Intervention for Early-childhood-caries
Not Applicable
Recruiting
- Conditions
- Early Childhood Caries
- Interventions
- Combination Product: Comprehensive prevention and treatmentCombination Product: Routine prevention
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 480
- Registration Number
- NCT05260216
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV
Not Applicable
- Conditions
- PTLDHLHCAEBV
- Interventions
- Drug: low-dose CD20 monoclonal antibody injection
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05258136
- Locations
- 🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China
Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer
Phase 2
Recruiting
- Conditions
- Locally Advanced Rectal Cancer
- Interventions
- Combination Product: Long-course chemoradiation, with or without Tislelizumab (PD-1 inhibitor)
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 186
- Registration Number
- NCT05245474
- Locations
- 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳Beijing Chaoyang Hospital, Capital Medical University, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath